Professional China Dandelion Flavonoids 4% - Genistein – Chenlv Detail:
CAS Number:446-72-0
Appearance: white fine powder
Test method: HPLC
Molecular Formula: C15H10O5
Molecular Weight:270.241
Specification: 98%
An isoflavonoid derived from soy products. It inhibits protein-tyrosine kinase and topoisomerase-II (DNA topoisomerases, type II) activity and is used as an antineoplastic and antitumor agent. Experimentally, it has been shown to induce G2 phase arrest in human and murine cell lines.
Additionally, genistein has antihelmintic activity. It has been determined to be the active ingredient in Felmingia vestita, which is a plant traditionally used against worms. It has shown to be effective in the treatment of common liver fluke, pork trematode and poultry cestode.
Further, genistein is a phytoestrogen which has selective estrogen receptor modulator properties. It has been investigated in clinical trials as an alternative to classical hormone therapy to help prevent cardiovascular disease in postmenopausal women 1.
Natural sources of genistein include tofu, fava beans, soybeans, kudzu, and lupin.
Product packing: 25kg/drum
Validity period: 2 years
Product detail pictures:
Related Product Guide:
Our focus on should be to consolidate and enhance the quality and repair of present products, in the meantime constantly establish new products to meet unique customers' requires for Professional China Dandelion Flavonoids 4% - Genistein – Chenlv, The product will supply to all over the world, such as: Philadelphia , Cologne , Belgium , Upon today, we've customers from all over the world, including USA, Russia, Spain, Italy, Singapore, Malaysia, Thailand, Poland, Iran and Iraq. The mission of our company is to provide the highest quality products with best price. We've been looking forward to doing business with you.
By Fanny from azerbaijan - 2017.08.15 12:36
Adhering to the business principle of mutual benefits, we have a happy and successful transaction, we think we will be the best business partner.
By Jean from Maldives - 2018.02.12 14:52